Raaj Medisafe India Ltd

Financial performance

• Revenue from operations ₹2,945.91 lakh; total income ₹2,961.36 lakh for quarter ended 30 Jun 2026.
• Other income ₹15.45 lakh; total income ₹2,961.36 lakh.
• Profit before tax ₹264.13 lakh; net profit ₹197.37 lakh for quarter ended 30 Jun 2026.
• Earnings per share: basic ₹1.20; diluted ₹1.20 for quarter ended 30 Jun 2026.
• Cost of materials consumed ₹2,129.76 lakh; changes in inventories −₹90.60 lakh.
• Finance costs ₹86.36 lakh; depreciation ₹70.67 lakh; other expenses ₹335.82 lakh.
• Segment revenue: Plastics ₹2,112.00 lakh; Hygiene ₹851.17 lakh; total ₹2,963.17 lakh.
• Segment profit: Plastics ₹350.74 lakh; Hygiene ₹31.08 lakh; total ₹381.82 lakh.
• Paid-up equity ₹1,642.43 lakh; reserves ₹3,228.95 lakh.
• Audit status: Standalone unaudited results; reviewed by Audit Committee.
• Notes: Plastic and Hygiene form the two reportable segments.

Segment & balance sheet snapshot

• Inter-segment revenue ₹1.81 lakh; gross segment revenue ₹2,961.36 lakh.
• Total segment assets: Plastics ₹7,174.99 lakh; Hygiene ₹5,385.41 lakh; ₹12,560.40 lakh.
• Unallocable corporate assets ₹32.00 lakh; total assets ₹12,592.40 lakh.
• Segment liabilities: Plastics ₹5,162.35 lakh; Hygiene ₹5,385.41 lakh; subtotal ₹10,547.76 lakh.
• Unallocable corporate liabilities ₹2,044.64 lakh; total liabilities ₹12,592.40 lakh.

Notes & compliance

• Business group comprises Plastic and Hygiene; figures regrouped for comparability.
• Quarter ended 30.06.2026 unaudited; results reviewed by Audit Committee; Board approved 12 Aug 2026.

Deviation status

• Mode of fund raising: Preferential Issue
• Date of raising funds: 26 March 2026
• Amount raised: Rs 18,01,25,000
• Report filed for quarter ended: June 30, 2026
• Monitoring agency: Not applicable
• Deviation/variation in use of funds: No
• Audit Committee comments: None
• Auditors comments: None
• No deviation or variation in utilization of funds
• Fund utilisation status: No deviation; utilisation in line with original allocations

CFO Appointment

• Type of change: appointment as Chief Financial Officer.
• Name and designation: Vipul Parakh, Chief Financial Officer.
• Effective date: August 12, 2026; term not specified.
• Reason: Appointment as CFO.
• Profile: Chartered Accountant with 28+ years' experience in service and manufacturing sectors.
• Key competencies: financial reporting, budgeting, compliance, and SAP implementation.
• Relationships: Not Applicable.

Financial results and disclosures

• Unaudited financial results for quarter ended June 30, 2026 approved.
• Limited Review Report by statutory auditor approved.
• Reconciliation of Share Capital Audit Report adopted.
• Shareholding Pattern approved.
• Integrated Corporate Governance Report approved.
• Statement of Investors' Complaints approved.
• Secretarial Compliance Report for year ended March 31, 2026 approved.
• Statement of variation of utilization of funds raised on 26.03.2026 through preferential allotment approved.
• Related party transactions for quarter ended June 30, 2026 considered and taken on record.

CFO appointment

• Resignation of Fatema Dadani Patel as CFO; Vipul Parakh appointed CFO effective 12 August 2026.

AGM notices and logistics

• Notice for 41st AGM approved; authorized to sign and issue.
• AGM to be held via VC/OAVM on 21 September 2026 at 3:00 PM.
• Cut-off date for e-voting fixed at 14 September 2026.
• Scrutinizer for AGM e-voting appointed: M. Maheshwari & Associates.
• Register of Members and Beneficial Owners closure fixed 15–21 September 2026.
• Quarter-end reports submitted to BSE: investors' complaints, shareholding pattern, governance, funds utilization, secretarial compliance.

Dematerialisation processing and listing

• Dematerialisation requests processed and confirmed to depositories.
• Securities dematerialised have been listed on the stock exchanges.
• Physical certificates were mutilated and cancelled after verification, with depository's name substituted as owner within 15 days.

Cessation of CFO

• Resignation of CFO Kanije Fatema Dadani Patel; effective 14 July 2026; to pursue new opportunities; vacates CFO/KMP role.

Preferential Issue of Equity Shares

• Board approved allotment of 3,275,000 equity shares at Rs.55 each on preferential basis
• Shares have face value of Rs.10 and include Rs.45 premium per share
• Shares rank pari-passu with existing equity shares
• In-principle approval received from BSE on March 12, 2026
• Application for listing approval to be made subsequently

Allottee Details

• Shares allotted to 17 non-promoter investors as per Annexure A
• Post-issue shareholding of allottees totals 19.94%
• Individual allotments range from 9,100 to 545,500 shares